Structural Studies of Human Histone Deacetylase 8 and Its Site-Specific Variants Complexed with Substrate and Inhibitors,
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Metal-dependent histone deacetylases (HDACs) require Zn(2+) or Fe(2+) to regulate the acetylation of lysine residues in histones and other proteins in eukaryotic cells. Isozyme HDAC8 is perhaps the archetypical member of the class I HDAC family and serves as a paradigm for studying structure-function relationships. Here, we report the structures of HDAC8 complexes with trichostatin A and 3-(1-methyl-4-phenylacetyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide (APHA) in a new crystal form. The structure of the APHA complex reveals that the hydroxamate CO group accepts a hydrogen bond from Y306 but does not coordinate to Zn(2+) with favorable geometry, perhaps due to the constraints of its extended pi system. Additionally, since APHA binds to only two of the three protein molecules in the asymmetric unit of this complex, the structure of the third monomer represents the first structure of HDAC8 in the unliganded state. Comparison of unliganded and liganded structures illustrates ligand-induced conformational changes in the L2 loop that likely accompany substrate binding and catalysis. Furthermore, these structures, along with those of the D101N, D101E, D101A, and D101L variants, support the proposal that D101 is critical for the function of the L2 loop. However, amino acid substitutions for D101 can also trigger conformational changes of Y111 and W141 that perturb the substrate binding site. Finally, the structure of H143A HDAC8 complexed with an intact acetylated tetrapeptide substrate molecule confirms the importance of D101 for substrate binding and reveals how Y306 and the active site zinc ion together bind and activate the scissile amide linkage of acetyllysine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In HDAC8, highly conserved D101 accepts hydrogen bonds from the two backbone amide groups flanking the scissile acetyllysine residue.37,38”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, D94 corresponds to acetyllysine binding residues D101 of hHDAC8 and S568 of hHDAC6 CD2 (refs 17, 30, 31).”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715 · cited 1×
“(32) and O (33), respectively, in order to improve each”
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 1×
“(32) and O (33), respectively, in order to improve each”
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,953 · cited 4×
“complex were performed with AMoRe (30) or PHASER (31)”
InfluentialHistone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114 · cited 1×
“These enzymes are implicated in a wide variety of biological processes such as apoptosis, differentiation, proliferation, and senescence (11).”
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714 · cited 4×
“Comparison of unliganded and liganded structures illustrates ligand-induced conformational changes in the L2 loop that likely accompany substrate binding and FIGURE 1: Proposed mechanism of histone deacetylase 8 (HDAC8) (17-19, 23-25).”
InfluentialGregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456 · cited 2×
“Phylogenic analyses reveal four distinct classes of human histone deacetylases: class I (HDAC(1) enzymes 1-3 and HDAC8), class II (HDAC enzymes 4-7, HDAC9, and HDAC10), class III (NAD-dependent human sirtuins 1-7), and class IV (HDAC11) (2, 10).”
Eberharter, A., & Becker, P. B. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf053 · Cited by 948
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710 · cited 10×
“0 (17, 18, 25), including the structure of the H143A HDAC8-substrate complex determined at pH 8.”
Influential
Research works printed but not linked: 3
- Gantt, S. L. (2006) Ph.D. Dissertation, University of Michigan.
- Schuetz, A., Min, J., Allali-Hassani, A., Loppnau, P., Kwiatkowski, N. P., Mazitschek, R., Edwards, A. M., Arrowsmith, C. H., Vedadi, M., Bochkarev, A., and Plotnikov, A. N. (2008) Crystal structure of the human histone deacetylase HDAC7 (DOI 10.2210/pdb3c0y/pdb). · doi:10.2210/pdb3c0y/pdb
- Leslie A. G. W., 1992, Crystallographic computing V: from chemistry to biology
Cited by
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Self-citationHistone deacetylase 6 structure and molecular basis of catalysis and inhibition
Hai, Y., & Christianson, D. W. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2134 · Cited by 521
“37,38 However, the corresponding residue in zCD2, N530, was offset such that S531 of zCD2 structurally aligned with D101 of HDAC8 and accepted a hydrogen bond from the backbone NH group of acetyllysine in substrates 1 and 8 (Fig.”
Self-citationStructure of Hdac3 Bound to Co-Repressor and Inositol Tetraphosphate
Watson, P. J., Fairall, L., Santos, G. M., & Schwabe, J. W. R. (2012) · Nature · doi:10.1038/nature10728 · Cited by 505
“1 ) diffracted to 2 A and the structure was solved by molecular replacement with an HDAC8 structur”
MethodLysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Inside HDAC with HDAC inhibitors
Bertrand, P. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.02.030 · Cited by 363
Structural insights into HDAC6 tubulin deacetylation and its selective inhibition
Miyake, Y., Keusch, J. J., Wang, L., Saito, M., Hess, D., Wang, X., Melancon, B. J., Helquist, P., Gut, H., & Matthias, P. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2140 · Cited by 315
“HDAC6 CD1-CD2 (encompassing amino acid residues 25−831, or 40−831) and HDAC6 CD1 (40−418) were expressed in Sf9 insect cells using the FlashBAC baculovirus system.”
BackgroundInfluentialShen, S., & Kozikowski, A. P. (2016) · ChemMedChem · doi:10.1002/cmdc.201500486 · Cited by 288
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
Lombardi, P. M., Cole, K. E., Dowling, D. P., & Christianson, D. W. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.004 · Cited by 277
“In the L2 loop of all class I and class II HDACs, D101 is strictly conserved to enforce substrate specificity: crystal structures of the inactive H143A and Y306F HDAC8 mutants complexed with a tetrapeptide substrate show that the side chain of D101 accepts hydrogen bonds from the backbone NH group of the scissile acet…”
BackgroundResultSelf-citationTcf1 and Lef1 transcription factors establish CD8+ T cell identity through intrinsic HDAC activity
Xing, S., Li, F., Zeng, Z., Zhao, Y., Yu, S., Shan, Q., Li, Y., Phillips, F. C., Maina, P. K., Qi, H. H., et al. (2016) · Nature Immunology · doi:10.1038/ni.3456 · Cited by 229
“The HDAC8 G271-L299 region constitutes an important component in its catalytic pocket 29 .”
InfluentialHistone deacetylase 10 structure and molecular function as a polyamine deacetylase
Hai, Y., Shinsky, S. A., Porter, N. J., & Christianson, D. W. (2017) · Nature Communications · doi:10.1038/ncomms15368 · Cited by 200
Self-citationHistone deacetylases: structural determinants of inhibitor selectivity
Micelli, C., & Rastelli, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.007 · Cited by 192
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
Porter, N. J., Mahendran, A., Breslow, R., & Christianson, D. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718823114 · Cited by 190
“hydrogen bonds from both backbone NH groups flanking the scissile acetyl–L-lysine residue (44, 45).”
BackgroundSelf-citationTargeting Class I Histone Deacetylases in a “Complex” Environment
Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.006 · Cited by 180
“Structures of both HDAC8 and HDAC1 with peptide inhibitors highlight the critical importance of an aspartate residue in binding of peptide substrates/inhibitors [32,33].”
BackgroundSuzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300837y · Cited by 165
Recent Advances in the Development of Polyamine Analogues as Antitumor Agents
Casero, R. A., & Woster, P. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900187v · Cited by 166
Whitehead, L., Dobler, M. R., Radetich, B., Zhu, Y., Atadja, P. W., Claiborne, T., Grob, J. E., McRiner, A., Pancost, M. R., Patnaik, A., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.030 · Cited by 164
Kaiser, F. J., Ansari, M., Braunholz, D., Concepción Gil-Rodríguez, M., Decroos, C., Wilde, J. J., Fincher, C. T., Kaur, M., Bando, M., Amor, D. J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu002 · Cited by 154
“To obtain independent data regarding the effect and severity of these mutations on protein function, we mapped mutations onto the previously reported crystal structure of HDAC8 (27,30) (Fig.”
BackgroundMethodInfluentialSelf-citationHistone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
Yan, W., Liu, S., Xu, E., Zhang, J., Zhang, Y., Chen, X., & Chen, X. (2013) · Oncogene · doi:10.1038/onc.2012.81 · Cited by 153
“It has been reported that residues D101 and Y306 in HDAC8 are crucial for HDAC8 activity (38, 39).”
BackgroundCole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Self-citationBürli, R. W., Luckhurst, C. A., Aziz, O., Matthews, K. L., Yates, D., Lyons, K. A., Beconi, M., McAllister, G., Breccia, P., Stott, A. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4011884 · Cited by 153
Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases
Porter, N. J., & Christianson, D. W. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.01.004 · Cited by 146
Self-citationA Proton-Shuttle Reaction Mechanism for Histone Deacetylase 8 and the Catalytic Role of Metal Ions
Wu, R., Wang, S., Zhou, N., Cao, Z., & Zhang, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103932d · Cited by 134
Marek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 122
Strategies To Design Selective Histone Deacetylase Inhibitors
Melesina, J., Simoben, C. V., Praetorius, L., Bülbül, E. F., Robaa, D., & Sippl, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202000934 · Cited by 118
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Banerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.039 · Cited by 108
Wu, R., Lu, Z., Cao, Z., & Zhang, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111104p · Cited by 108
Neelarapu, R., Holzle, D. L., Velaparthi, S., Bai, H., Brunsteiner, M., Blond, S. Y., & Petukhov, P. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2001025 · Cited by 117
“3-Azido-5-azidomethylbenzoic acid methyl ester (11)—To a stirring solution of azido-alcohol 10 (3 g, 14.”
MethodSmall Molecule Inhibitors of Zinc-dependent Histone Deacetylases
Wagner, F. F., Weïwer, M., Lewis, M. C., & Holson, E. B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0226-1 · Cited by 107
Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations
Gantt, S. L., Joseph, C. G., & Fierke, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033399 · Cited by 86
Self-citationThangapandian, S., John, S., Sakkiah, S., & Lee, K. W. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.06.024 · Cited by 87
On the inhibition of histone deacetylase 8
Estiu, G., West, N., Mazitschek, R., Greenberg, E., Bradner, J. E., & Wiest, O. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.080 · Cited by 82
HDAC8 and STAT3 repress BMF gene activity in colon cancer cells
Kang, Y., Nian, H., Rajendran, P., Kim, E., Dashwood, W. M., Pinto, J. T., Boardman, L. A., Thibodeau, S. N., Limburg, P. J., Löhr, C. V., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.422 · Cited by 82
Núñez‐Álvarez, Y., & Suelves, M. (2021) · FEBS Journal · doi:10.1111/febs.15895 · Cited by 94
HDAC8 substrates: Histones and beyond
Wolfson, N. A., Pitcairn, C. A., & Fierke, C. A. (2013) · Biopolymers · doi:10.1002/bip.22135 · Cited by 80
Self-citationDowling, D. P., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2010) · Biochemistry · doi:10.1021/bi1005046 · Cited by 81
“In the structure of D101L Zn2þ-HDAC8 (36), a crystallographic dimer forms such that inhibitor binding in one monomer Table 4: Metal Ion Dependence of HDAC8 Inhibition”
InfluentialSelf-citationEpigenetic mechanisms regulate stage differentiation in the minimized protozoan Giardia lamblia
Sonda, S., Morf, L., Bottová, I., Baetschmann, H., Rehrauer, H., Caflisch, A., Hakimi, M., & Hehl, A. B. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07062.x · Cited by 86
“To gain further insights into the structure-function basis of giardial HDAC, a homology model was generated using the recently resolved structure of human HDAC8 as a template (Fig.”
BackgroundInfluentialPathological Role of HDAC8: Cancer and Beyond
Kim, J. Y., Cho, H., Yoo, J. H., Kim, G. W., Jeon, Y. H., Lee, S. W., & Kwon, S. H. (2022) · Cells · doi:10.3390/cells11193161 · Cited by 89
“D101 plays a critical role in substrate binding by directing conformational changes of the L2 loop from an unliganded form to a liganded form [26].”
BackgroundWu, R., Hu, P., Wang, S., Cao, Z., & Zhang, Y. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct9005322 · Cited by 86
HDAC1/2/3 are major histone desuccinylases critical for promoter desuccinylation
Li, J., Lu, L., Liu, L., Ren, X., Chen, J., Yin, X., Xiao, Y., Li, J., Wei, G., Huang, H., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00573-9 · Cited by 85
Vanaja, G. R., Ramulu, H. G., & Kalle, A. M. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0231-4 · Cited by 74
Metabolism as a key to histone deacetylase inhibition
Rajendran, P., Williams, D. E., Ho, E., & Dashwood, R. H. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.557713 · Cited by 78
“…pocket in the presence and absence of bound ligands (Finnin et al., 1999; Vannini et al., 2004, 2007; Somoza et al., 2004; Bottomley et al., 2008; Dowling et al., 2008; Schuetz et al., 2008; Ficner, 2009), and computational modeling in silico (Vannini et al., 2007; Nian et al., 2008, 2009b;…”
BackgroundTargeting of HDAC8 and investigational inhibitors in neuroblastoma
Oehme, I., Deubzer, H. E., Lodrini, M., Milde, T., & Witt, O. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/14728220903241658 · Cited by 75
“Drugs (2009) 18(11) For HDAC8, the structure is known and very well characterized [98].”
BackgroundZinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
Li, Y., Wang, F., Chen, X., Wang, J., Zhao, Y., Li, Y., & He, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190122144949 · Cited by 80
Structural basis for the design and synthesis of selective HDAC inhibitors
Micco, S. D., Chini, M. G., Terracciano, S., Bruno, I., Riccio, R., & Bifulco, G. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.036 · Cited by 80
Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8
Porter, N. J., & Christianson, D. W. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00330 · Cited by 71
Self-citationInnovative Strategies for Selective Inhibition of Histone Deacetylases
Maolanon, A. R., Madsen, A. S., & Olsen, C. A. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.06.011 · Cited by 72
Rodrigues, D. A., Pinheiro, P. D. S. M., Sagrillo, F. S., Bolognesi, M. L., & Fraga, C. A. M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21701 · Cited by 70
Andreoli, F., Barbosa, A. J. M., Parenti, M. D., & Río, A. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581918 · Cited by 68
General Base–General Acid Catalysis in Human Histone Deacetylase 8
Gantt, S. M. L., Decroos, C., Lee, M. S., Gullett, L. E., Bowman, C. M., Christianson, D. W., & Fierke, C. A. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01327 · Cited by 67
Self-citationDecroos, C., Bowman, C. M., Moser, J.-A. S., Christianson, K. E., Deardorff, M. A., & Christianson, D. W. (2014) · ACS Chemical Biology · doi:10.1021/cb5003762 · Cited by 66
Self-citationThangapandian, S., John, S., Sakkiah, S., & Woo, L. K. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.07.007 · Cited by 68
Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy
Pojani, E., & Barlocco, D. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200203113926 · Cited by 68
Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC Isoforms
Zessin, M., Meleshin, M., Praetorius, L., Sippl, W., Bařinka, C., & Schutkowski, M. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00863 · Cited by 67
Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6
Porter, N. J., Wagner, F. F., & Christianson, D. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00367 · Cited by 64
Self-citationTabackman, A. A., Frankson, R., Marsan, E. S., Perry, K., & Cole, K. E. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.06.023 · Cited by 60
“D101, which functions in substrate binding (Vannini et al., 2007; Dowling et al., 2008).”
BackgroundInfluentialBallante, F., & Marshall, G. R. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00603 · Cited by 66
Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach
Sixto‐López, Y., Bello, M., & Correa‐Basurto, J. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00304-2 · Cited by 70
“For the PDBs in which there were no co-crystallized ligands, a well-known selective ligand was used as indicated: HDAC1, Quisinostat [34]; HDAC2, AC1OCG0B [35]; HDAC3, RGFP966 [36]; HDAC4, TFMK [37], and as a selective HDAC4 compound, KEE [38]; HDAC6, Trichostatin A (TSA) [39]; HDAC7, TMP269 [11]; and HDAC8, APHA [40]…”
MethodInfluentialNon-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
Frühauf, A., & Meyer‐Almes, F. (2021) · Molecules · doi:10.3390/molecules26175151 · Cited by 62
Decroos, C., Clausen, D. J., Haines, B. E., Wiest, O., Williams, R. M., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00010 · Cited by 58
Self-citationBotta, C. B., Cabri, W., Cini, E., Cesare, L. D., Fattorusso, C., Giannini, G., Persico, M., Petrella, A., Rondinelli, F., Rodriquez, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101373a · Cited by 57
Sixto‐López, Y., Gómez-Vidal, J. A., de Pedro, N., Bello, M., Rosales‐Hernández, M. C., & Correa‐Basurto, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-67112-4 · Cited by 60
Structure-Based Identification of HDAC8 Non-histone Substrates
Alam, N., Zimmerman, L., Wolfson, N. A., Joseph, C. G., Fierke, C. A., & Schueler-Furman, O. (2016) · Structure · doi:10.1016/j.str.2016.02.002 · Cited by 52
“The side chain of D101 has been shown to play a critical role for HDAC8 substrate binding and activity (Vannini et al., 2007; Dowling et al., 2008).”
InfluentialSelf-citationThe enzyme activity of histone deacetylase 8 is modulated by a redox-switch
Jänsch, N., Meyners, C., Muth, M., Kopranovic, A., Witt, O., Oehme, I., & Meyer‐Almes, F. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.013 · Cited by 51
“The L2-loop is highly unordered in crystal structures of unbound HDAC8 and becomes more ordered upon binding to small molecule ligands [28].”
BackgroundThe Interaction of Zinc(II) and Hydroxamic Acids and a Metal‐Triggered Lossen Rearrangement
Ducháčková, L., & Roithová, J. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200901645 · Cited by 52
Bai, H., Velaparthi, S., Pieffet, G. P., Pennington, C., Mahesh, A., Holzle, D. L., Brunsteiner, M., van Breemen, R. B., Blond, S. Y., & Petukhov, P. A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9005077 · Cited by 48
Giannini, G., Vesci, L., Battistuzzi, G., Vignola, D., Milazzo, F. M., Guglielmi, M. B., Barbarino, M., Santaniello, M., Fantò, N., Mor, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008209 · Cited by 52
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Fontana, A., Cursaro, I., Carullo, G., Gemma, S., Butini, S., & Campiani, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710014 · Cited by 50
“H142 serves as the general base catalyst, whereas H143 serves as both the general acid and the general base catalyst (Figure 1) [15,16].”
BackgroundThangapandian, S., John, S., Lee, Y., Kim, S., & Lee, K. W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129440 · Cited by 47
“To date 18 crystal structures were determined by various research groups among which only 8 are native HDAC8 bound with different inhibitors [23,39–42].”
BackgroundDecroos, C., Christianson, N. H., Gullett, L. E., Bowman, C. M., Christianson, K. E., Deardorff, M. A., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00881 · Cited by 46
Self-citationHou, X., Du, J., Liu, R., Zhou, Y., Li, M., Xu, W., & Fang, H. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500762z · Cited by 44
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
“44 3F07 30 December 2008 1164 Homo sapiens [40]”
InfluentialShinsky, S. A., & Christianson, D. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00079 · Cited by 41
Self-citationLoop Interactions and Dynamics Tune the Enzymatic Activity of the Human Histone Deacetylase 8
Kunze, M. B. A., Wright, D. W., Werbeck, N. D., Kirkpatrick, J., Coveney, P. V., & Hansen, D. F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408184x · Cited by 41
Ortore, G., Colo, F. D., & Martinelli, A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900288e · Cited by 40
Deardorff, M. A., Porter, N. J., & Christianson, D. W. (2016) · Protein Science · doi:10.1002/pro.3030 · Cited by 37
“enable crystallization with an unreacted substrate).(36,39) These interactions orient and polarize”
BackgroundSelf-citationMetal-assisted Lossen Rearrangement
Jašíková, L., Hanikýřová, E., Škríba, A., Jašík, J., & Roithová, J. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo300031f · Cited by 39
Castañeda, C. A., Wolfson, N. A., Leng, K. R., Kuo, Y.-M., Andrews, A. J., & Fierke, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811026 · Cited by 38
“Structures of peptides bound to HDAC8 are in an extended conformation (19, 22, 30).”
BackgroundSelf-citationHaider, S., Joseph, C. G., Neidle, S., Fierke, C. A., & Fuchter, M. J. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.128 · Cited by 39
Self-citationTaha, T. Y., Aboukhatwa, S. M., Knopp, R. C., Ikegaki, N., Abdelkarim, H., Neerasa, J., Lu, Y., Neelarapu, R., Hanigan, T. W., Thatcher, G. R. J., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00126 · Cited by 38
Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors
Wang, F., Lu, W. Z., Zhang, T., Dong, J., Gao, H., Li, P., Wang, S., & Zhang, J. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.021 · Cited by 38
Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation
Cini, E., Faltoni, V., Petricci, E., Taddei, M., Salvini, L., Giannini, G., Vesci, L., Milazzo, F. M., Anastasi, A. M., Battistuzzi, G., et al. (2018) · Chemical Science · doi:10.1039/c7sc05266a · Cited by 43
Kutil, Z., Skultetyova, L., Rauh, D., Meleshin, M., Šnajdr, I., Nováková, Z., Mikesova, J., Pavlíček, J., Hadzima, M., Baranová, P., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801680r · Cited by 39
“32 18,631 GGMRGMK(Ac)GLVYET Citrate synthase, mitochondrial (76, 10, 40) Substrate in 4/4 18.”
BackgroundKumbhar, N., Nimal, S., Barale, S. S., Kamble, S. A., Bavi, R., Sonawane, K. D., & Gacche, R. N. (2022) · Scientific Reports · doi:10.1038/s41598-022-05698-7 · Cited by 41
Federico, S., Khan, T., Fontana, A., Brogi, S., Benedetti, R., Sarno, F., Carullo, G., Pezzotta, A., Saraswati, A. P., Passaro, E., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114409 · Cited by 40
How the flexibility of human histone deacetylases influences ligand binding: an overview
Deschamps, N., Simões‐Pires, C. A., Carrupt, P., & Nurisso, A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.004 · Cited by 39
Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases
Christianson, D. W. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00801 · Cited by 37
Self-citationBermúdez-Lugo, J. A., Pérez-González, O. A., Rosales‐Hernández, M. C., Ilizaliturri‐Flores, I., Trujillo-Ferrara, J. G., & Correa‐Basurto, J. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1240-z · Cited by 36
“To use all of the 3-D structures of HDAC attained from the experimental methods, a search of the PDB was performed, which found 14 structures that belonged to isoform 8 (PDB codes: 1T64 [20], 1T67 [20], 1T69 [20], 1VKG [20], 1W22 [21], 2V5W [22], 2V5X [22], 3EW8 [22], 3EWF [23], 3EZP [23], 3EZT [23], 3F0R [23], 3F06 […”
MethodWolff, B., Jänsch, N., Sugiarto, W. O., Frühschulz, S., Lang, M., Altintas, R., Oehme, I., & Meyer‐Almes, F. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111756 · Cited by 34
Wu, Y.-W., Hsu, K., Lee, H., Huang, T., Lin, T. E., Chen, Y., Sung, T.-Y., Liou, J., Hwang‐Verslues, W. W., Pan, S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00205 · Cited by 35
“The zinc binding group is critical for HDAC inhibitor recognition (Dowling et al., 2008).”
BackgroundPorter, N. J., Christianson, N. H., Decroos, C., & Christianson, D. W. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01014 · Cited by 33
Self-citationMechanisms of Metal-Dependent Hydrolases in Metabolism
Hernick, M., & Fierke, C. A. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00178-7 · Cited by 37
Self-citationThaler, F., Moretti, L., Amici, R., Abate, A., Colombo, A., Carenzi, G. E. A., Fulco, M. C., Boggio, R., Dondio, G. M., Gagliardi, S., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.11.010 · Cited by 33
Porter, N. J., Shen, S., Barinka, C., Kozikowski, A. P., & Christianson, D. W. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00487 · Cited by 30
Self-citationIlies, M., Dowling, D., Lombardi, P. M., & Christianson, D. W. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.100 · Cited by 31
Self-citationLiu, J., Zhu, Y., He, Y., Zhu, H., Gao, Y. Q., Li, Z., Zhu, J., Sun, X., Fang, F., Wen, H., et al. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1590241 · Cited by 30
Arrar, M., Turnham, R., Pierce, L., de Oliveira, C. A. F., & McCammon, J. A. (2013) · Protein Science · doi:10.1002/pro.2190 · Cited by 30
Structural Biology of Human Metal-Dependent Histone Deacetylases
Schapira, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_10 · Cited by 32
“2008) and HDAC8 (Dowling et al. 2008; Dowling et al. ; Somoza et al. 2004; Vannini et al. 2004; Vannini et al. 2007) solved since confirmed the general architecture revealed by the seminal work on the bacterial enzyme, and define a set of canonical features (Figure 2): (1) a funnel-shaped lysine binding channel locate…”
BackgroundInfluentialGanai, S. A., Shanmugam, K., & Mahadevan, V. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2013.879073 · Cited by 27
Metadata
- Authors
- Dowling, D. P., Gantt, S. L., Gattis, S. G., Fierke, C. A., & Christianson, D. W.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Christianson, David W.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-11-24
- Volume
- 47
- Issue
- 51
- Pages
- 13554-13563
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- PMC
- PMC2635894
- OpenAlex
- W2126891469
- Cited by
- 200
- References
- 38
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 13 · 2020: 11 · 2019: 13 · 2018: 15 · 2017: 18 · 2016: 16 · 2015: 13 · 2014: 12 · 2013: 11 · 2012: 12
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (GM40602, R01GM040602, GM49758, R01GM049758)
- National Institute of Biomedical Imaging and Bioengineering (P30EB009998)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC8, trichostatin A, AphA, hydroxamate inhibitors, substrate binding site, class I HDACs, structure-function relationship
- MeSH terms
- Binding Sites, Catalysis, Histone Deacetylases, Humans, Hydroxamic Acids, Molecular Conformation, Mutation, Peptides, Protein Binding, Protein Conformation, Pyrroles, Repressor Proteins, Structure-Activity Relationship, Substrate Specificity, Crystallography, X-Ray, Catalytic Domain, Polyunsaturated Alkamides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.